Certain classes of weight loss and diabetes medications like GLP-1 and SGLT2 inhibitors have been found to reduce the risk of heart attacks, strokes, and death in stroke survivors. A study evaluated 7,044 adults admitted for acute ischemic stroke and found that those taking these medications had a 74% lower risk of death and an 84% lower risk of heart attack. The risk of another stroke was also reduced by 67% in those taking SGLT2 inhibitors. These medications are critical in managing the risks associated with stroke survivors and improving their quality of life. The benefits were seen even after adjusting for other risk factors.
Source link
Weight Loss Drugs May Lower Risk Of Subsequent Heart Attacks, Strokes In Stroke Survivors: Study
